The largest database of trusted experimental protocols

1 2 dipalmitoyl sn glycero 3 phosphoethanolamine dppe

Manufactured by Avanti Polar Lipids
Sourced in United States

1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) is a synthetic phospholipid commonly used in laboratory research. It is a major component of biological membranes and serves as a precursor for the synthesis of other phospholipids. DPPE can be utilized for various applications in cell biology, biophysics, and membrane research.

Automatically generated - may contain errors

6 protocols using 1 2 dipalmitoyl sn glycero 3 phosphoethanolamine dppe

1

Fluorescent-Labeled CAR Peptide Conjugation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cholesterol, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(poly ethylene glycol)-2000] (DSPE-PEG2000); and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) were purchased from Avanti Polar Lipids Inc. (Alabaster, AL). N-Succinimidyl 1,3-(2-pyridyldithio) propionate (SPDP) was obtained from Molecular Biosciences (Boulder, CO). Carboxyfluorescein (FAM)-labeled CAR peptide (currently licensed by Vascular BioSciences, Durham, NC) containing an extra cysteine for conjugation through the free sulfhydryl was custom synthesized (LifeTein, LLC, Somerset, Nj). The empirical formula for the fluorescent-labeled CAR is FAM-Cys-6-aminohexanoic acid-(CARSKNKDC)-amide. The extra cysteine was used for attaching the fluorescent probe and thus to keep the cyclic form of the peptide intact, which occurs via a disulfide bridge between Cys1 and Cys9. All other chemicals, purchased either from Fisher Scientific (Pittsburgh, PA) or Sigma-Aldrich Inc. (St Louis, MO), were of analytical grades and used without further purification. Diseased and control endothelial (ECs), SMC, and fibroblast cells (FBCs) were either isolated from the pulmonary arteries of Sugen/hypoxia-induced-PAH rats by Cell Biologic Inc. (Chicago, IL) or purchased from the same vendor. All media supplements were purchased from Invitrogen (Carlsbad, CA).
+ Open protocol
+ Expand
2

Optimizing Chocolate Formulations with Lipids

Check if the same lab product or an alternative is used in the 5 most similar protocols
After the refining processes, various phospholipids, MAGs, and FFAs were added to the CB. Cocoa butter was melted at 80 °C for 15 min, and the minor components were mixed in by hand until fully dissolved. Chocolate samples were molten in a double boiler at 60 °C and minor components added and mixed by hand until fully dissolved. Minor components were fully incorporated within 5 min of mixing. 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) (Avanti Polar-Lipids, Alabaster, Alabama, USA) and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) (Avanti Polar-Lipids, Alabaster, Alabama, USA) were each added to refined CB at 0.1% w/w levels. Glyceryl monostearate (GMS) (Alphadim 90 SBK from Caravan Ingredients, Lenexa, Kansas, USA), glyceryl monopalmitate (GMP) (Alphadim 90 PBK from Caravan Ingredients, Lenexa, Kansas, USA), and glyceryl monooleate (GMO) (1-monoolein, Alfa Chemistry, New York, USA) were added at 0.5% w/w levels. Gas chromatography revealed that the GMS was mainly Stearic acid (88.3%), the GMP was not only palmitic acid (56.9%) but also had significant amounts of Stearic acid (40.5%), and GMO was mainly oleic acid (81.8% oleic acid). Stearic acid, palmitic acid, and oleic acid (Fisher Scientific Company, Ottawa, Ontario, Canada), as free fatty acids, were added at 0.5% w/w levels. DMPC and DPPE were added to the chocolate samples at 0.1% (w/w) levels.
+ Open protocol
+ Expand
3

Nanobubble Synthesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Materials for nanobubble synthesis are same as described in a previous study22 (link). Lipids 1,2-dibehenoyl-sn-glycero-3-phosphocholine (DBPC), 1,2 Dipalmitoyl-sn-Glycero-3-Phosphate (DPPA), and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) were purchased from Avanti Polar Lipids (Alabaster, AL, USA). 1,2-distearoyl-snglycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000] (ammonium salt) (mPEG-DSPE) was obtained from Laysan Lipids (Arab, AL, USA). Pluronic L10 was obtained from BASF Corporation (Florham Park, NJ, USA) and glycerol was purchased from Thermo Fisher Scientific (Waltham, MA, USA). All chemicals were used directly without further purification. Octafluoropropane (C3F8) gas was obtained from FluoroMed, L.P. (Round Rock, TX, USA).
+ Open protocol
+ Expand
4

TLR2 Binding Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
1,2-Dipalmitoyl-sn-glycero-3-phospho-ethanolamine
(DPPE) and egg PC (l-α-phosphatidylcholine) were purchased
from Avanti Polar Lipids (Alabaster, AL). Recombinant mouse TLR2-Fc
protein was purchased from R&D Systems (Minneapolis, MN). Phospholipase
D (PLD) from Streptomyces sp. and Streptomyces chromofuscus were obtained from Enzo
Life Sciences (Farmingdale, NY). Horseradish peroxidase-labeled goat
anti-human IgG Fc antibody was purchased from Millipore (Billerica,
MA). ABTS solution substrate for horseradish peroxidase was from Invitrogen
(Grand Island, NY). OxPAPC was from InvivoGen (San Diego, CA). The
fluorenemethyl ester of 3,6-dioxohexanoic acid (DOHA-Fm), CEP-modified
human serum albumin (CEP-HSA) and chicken egg ovalbumin (CEP-CEO),
and polyclonal rabbit anti-CEP-KLH antibody were prepared as described
previously.1 (link) Mouse anti-human TLR2 LEAF
antibody (CD282) was from BioLegend (San Diego, CA). Calcein AM and
Accutase were from BD Biosciences (San Jose, CA). Goat anti-mouse
IgG-AlexaFluor 488 was from Invitrogen (Carlsbad, CA). All other chemicals
were from Sigma-Aldrich and were analytical grade.
+ Open protocol
+ Expand
5

Glycyrrhiza glabra Extract Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols

ChemicalsExtract from Glycyrhizza glabra roots from FLOS (Mokrsko, Poland) was obtained by methanol extraction in a Soxhlet apparatus. Then, the extract was subjected to two nanofiltration processes, first using a 3-kDa (Merckmilipore, Darmstadt, Germany) membrane, then, the second, with the use of a 0.5-kDa membrane (TriSep, Sterlitech, Auburn, WA, USA). The process was conducted using Amicon Stirred Cell with a total volume of 200 mL (Merkmilipore). As a result, two fractions of extracts were used during the research, crude extract marked as GgC and purified extract (with molecules size between 3 kDa and 0.5 kDa), GgP.
In the presented studies, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE, 99%; from Avanti Polar Lipids (Alabaster, AL, USA)) was used as the film and liposome forming substance. Chloroform of high-purity Uvasol (Merck, Warszawa, Poland) was used to prepare the Langmuir monolayer. Dulbecco′s Phosphate Buffered Saline (Sigma Aldrich, Poznań wielkopolskie, Poland) was applied as a solvent to prepare saponins solution or as a subphase.
Deuterium oxide was purchased from Merck KGaA (Darmstadt, Germany).
+ Open protocol
+ Expand
6

Encapsulated Lipid Particle Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELIP were prepared and shipped overnight on ice packs from the University of Texas Health Science Center, Houston to the University of Cincinnati. The lipid formulation as described by Buchanan et al. (2008) (link) consisted of L-α-phosphatidylcholine (chicken egg; EPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-glycero-3-[phosphor-rac-1-glycerol] (DPPG), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) (Avanti Polar Lipids, Alabaster, AL, USA), and cholesterol (CH) (Sigma Aldrich St. Louis, MO, USA) in the molar ratio 27:42:8:8:15. Each 6 mg ELIP vial was reconstituted with 0.6 ml of 0.2 μm-filtered deionized water (NANOPure, Barnstead International, Dubuque, IA, USA). ELIP were diluted in porcine plasma (Lampire Biologicals, Pipersville, PA, USA) at 37 °C and 93 ± 2 % dissolved oxygen (DO) to yield a final lipid concentration of 0.05 mg/ml (6.4×108 liposomes/ml) (Hamilton et al. 2004 (link); Smith et al. 2007 (link); Kopechek et al. 2011 (link); Raymond et al. 2013 ).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!